Functional characterization and m‐RNA expression of 5‐HT receptors mediating contraction in human umbilical artery
- 1 July 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (5) , 1247-1255
Abstract
5‐HT1‐like and 5‐HT2 receptors have both been described to mediate contractions to 5‐HT in the human umbilical artery (HUA). However, the nature of the 5‐HT receptor subtypes is unknown. In isometric force studies with ring preparations of HUA α‐methyl‐5‐hydroxytryptamine (α‐Me‐5‐HT) and 5‐hydroxytryptamine (5‐HT) contracted HUA with pED50 values of 8.04 and 7.74, respectively. In the presence of a subthreshold concentration of another vasoconstrictor sumatriptan and 5‐nonyloxytryptamine elicited concentration‐dependent contractions with pEC50 values of 7.21 and 7.67, respectively. In the presence of the selective 5‐HT1B/D receptor antagonist GR127935, contractile responses elicited by sumatriptan and 5‐nonyloxytryptamine were competitively antagonized (pKB 9.01 and 9.02, respectively). In the experiments with 5‐HT, GR127935 appeared to be non‐competitive with shallow Schild plot slopes. The data were fitted with two linear regression lines and the calculated pKB of the high affinity component (8.90) was comparable to that expected for GR127935 at the 5‐HT1B/1D receptor. Several 5‐HT2 selective receptor antagonists (spiperone, cyproheptadine, pirenperone) competitively inhibited responses to 5‐HT. The selective 5‐HT2A antagonist ketanserin against sumatriptan and 5‐nonyloxytryptamine behaved as a weak antagonist while against 5‐HT demonstrated a competitive antagonism (pKB 8.56). Using specific primers for human 5‐HT1B, 5‐HT1D and 5‐HT2A receptor genes, the reverse transcriptase‐polymerase chain reaction revealed mRNA expression of 5‐HT1B and 5‐HT2A receptors in the HUA. The results suggest that the HUA has a functional population of 5‐HT1B and 5‐HT2A receptor subtypes which are involved in the contractile response to 5‐HT. Contractions mediated by 5‐HT1B receptors can be ‘uncovered’ by exposure to other vasoactive agents. British Journal of Pharmacology (1999) 127, 1247–1255; doi:10.1038/sj.bjp.0702647Keywords
This publication has 51 references indexed in Scilit:
- Involvement of 5‐HT1B/1D and 5‐HT2A receptors in 5‐HT‐induced contraction of endothelium‐denuded rabbit epicardial coronary arteriesBritish Journal of Pharmacology, 1997
- Contractile Responses to Sumatriptan in Isolated Bovine Pulmonary Artery RingsJournal of Cardiovascular Pharmacology, 1995
- Expression of serotonin receptor mRNAs in blood vesselsFEBS Letters, 1995
- The endothelium contributes to the contractile responses of the human umbilical artery to 5-hydroxytryptamine and endothelin-1 under low but not high conditionsCanadian Journal of Physiology and Pharmacology, 1994
- Evolution of a Novel Series of [(N,N-Dimethylamino)propyl]- and Piperazinylbenzanilides as the First Selective 5-HT1D AntagonistsJournal of Medicinal Chemistry, 1994
- Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Mechanisms Involved in Serotonin-Induced VasodilatationJournal of Vascular Research, 1990
- INTERACTION BETWEEN PLATELET‐RELEASED SEROTONIN AND THROMBOXANE A2 ON HUMAN DIGITAL ARTERIESClinical and Experimental Pharmacology and Physiology, 1986
- Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calfNaunyn-Schmiedeberg's Archives of Pharmacology, 1984
- Cocaine-Induced Supersensitivity in the Human Umbilical ArteryCanadian Journal of Physiology and Pharmacology, 1974